Har Grover, MBA, ICD.D

Mr. Har Grover is an entrepreneur, investor, senior executive and strategist with over 30 years of experience in healthcare, life sciences and technology. He has worked with growth companies at all stages, from start-up to commercialization, to going public and growing through the $1 billion revenue mark. He has helped companies enter new markets both in Canada and internationally – organically and through M&A, strategic alliances, and joint ventures.

Mr. Grover is presently the CEO of GeneTether Inc.. He was previously Chairman and CEO of Scientus Pharma, Co-Founder and CEO of CannScience Innovations, as well as Founder and Managing Director of Nucleus GC.

He has served on several corporate and non-profit boards, including Chair of Armour Therapeutics, Chair of Crohn’s and Colitis Canada, Board Director of Medworxx, and Board Director of MedcannAccess. Mr. Grover has an undergraduate degree in life sciences, an MBA, and has obtained professional CMC and ICD.D designations.

Other Team Members

Shana Kelley, PhD

Distinguished Professor, University of Toronto; Serial Entrepreneur

Ken Newport, ICD.D, CPA

Chair, Board of Directors, BioCanRx; Life Sciences Entrepreneur

Ken Lawless, MSc

Executive Director, Ottawa Health Innovation Hub

John Morrison, BSc

Former Group President, Healthcare, MDS Inc.